Variable plasma propranolol levels in thyrotoxicosis

The New England Journal of Medicine
S RubenfeldP O Kohler


No abstract listed.


Jan 1, 1976·Clinical Pharmacokinetics·G Johnsson, C G Regàrdh
Nov 1, 1977·Clinics in Endocrinology and Metabolism·L Landsberg
Jan 1, 1976·Clinical Pharmacokinetics·M Eichelbaum
Feb 3, 1977·The New England Journal of Medicine·M ErikssonP O Kohler
May 1, 1975·The American Journal of Cardiology·W FrishmanT Killip
Oct 2, 1975·The New England Journal of Medicine·D J Greenblatt, J Kock-Weser
May 12, 1973·British Medical Journal·D G McLartyP Horton
May 25, 1974·Lancet·W MichieP D Bewsher
Jan 1, 1968·Acta Endocrinologica·R M Buckle
Feb 1, 1970·The American Journal of the Medical Sciences·D HuntG Hoffmann
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Feb 1, 1972·The Journal of Clinical Endocrinology and Metabolism·A M Michelakis, R G McAllister
Mar 1, 1972·Clinical Pharmacology and Therapeutics·C R Cleaveland, D G Shand
Nov 1, 1974·Clinical Pharmacology and Therapeutics·D T LowenthalW J Cirksena
Jun 1, 1973·Annals of Surgery·T C LeeJ J Canary
Sep 1, 1966·The American Journal of Cardiology·R H GrantK Sinclair
Jan 1, 1972·Pharmacology·R Zacest, J Koch-Weser
Feb 27, 1971·British Medical Journal·D J ColtartD G Shand
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates
Jan 1, 1968·Journal of Pharmaceutical Sciences·S RiegelmanM Rowland

❮ Previous
Next ❯


Jan 1, 1982·European Journal of Clinical Pharmacology·A AroH Sundquist
Jan 1, 1982·European Journal of Clinical Pharmacology·B HallengrenE Wåhlin-Boll
Jan 1, 1981·European Journal of Clinical Pharmacology·J FeelyI H Stevenson
Oct 1, 1980·European Journal of Clinical Pharmacology·O R NilssonL Tegler
Jan 1, 1980·Pharmacology & Therapeutics·L S Dreifus, J Morganroth
Mar 27, 2012·The Medical Clinics of North America·Joanna Klubo-Gwiezdzinska, Leonard Wartofsky
Jul 1, 1990·The American Journal of Medicine·W L IsleyH Gibbs
Jul 1, 1992·The American Journal of Medicine·D L Geffner, J M Hershman
Jan 1, 1980·British Journal of Pharmacology·T Ishizaki, K Tawara
Jun 1, 1982·British Journal of Clinical Pharmacology·N R PedenJ Crooks
Jul 1, 1981·British Journal of Clinical Pharmacology·J FeelyI H Stevenson
Nov 1, 1980·Pacing and Clinical Electrophysiology : PACE·R H MillerW P Baker
Dec 2, 1998·British Journal of Clinical Pharmacology·R P Choudhury, J MacDermot
Mar 1, 1986·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology·U AngeråsP O Hasselgren
Jul 1, 1981·Disease-a-month : DM·P I Hartzband, D H Solomon

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
R HellmanW D Mason
British Journal of Clinical Pharmacology
L E MurchisonP D Bewsher
British Journal of Clinical Pharmacology
J FeelyI H Stevenson
The American Journal of Emergency Medicine
D D Brunette, C Rothong
© 2021 Meta ULC. All rights reserved